Suppr超能文献

c-Cbl 自身抑制和磷酸化依赖性激活的结构基础。

Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.

机构信息

The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Glasgow, G61 1BD, United Kingdom.

出版信息

Nat Struct Mol Biol. 2012 Jan 22;19(2):184-92. doi: 10.1038/nsmb.2231.

Abstract

Cbls are RING ubiquitin ligases that attenuate receptor tyrosine kinase (RTK) signal transduction. Cbl ubiquitination activity is stimulated by phosphorylation of a linker helix region (LHR) tyrosine residue. To elucidate the mechanism of activation, we determined the structures of human CBL, a CBL-substrate peptide complex and a phosphorylated-Tyr371-CBL-E2-substrate peptide complex, and we compared them with the known structure of a CBL-E2-substrate peptide complex. Structural and biochemical analyses show that CBL adopts an autoinhibited RING conformation, where the RING's E2-binding surface associates with CBL to reduce E2 affinity. Tyr371 phosphorylation activates CBL by inducing LHR conformational changes that eliminate autoinhibition, flip the RING domain and E2 into proximity of the substrate-binding site and transform the RING domain into an enhanced E2-binding module. This activation is required for RTK ubiquitination. Our results present a mechanism for regulation of c-Cbl's activity by autoinhibition and phosphorylation-induced activation.

摘要

Cbls 是 RING 泛素连接酶,可减弱受体酪氨酸激酶(RTK)信号转导。Cbl 的泛素化活性受连接螺旋区(LHR)酪氨酸残基磷酸化的刺激。为了阐明激活机制,我们测定了人 CBL、CBL-底物肽复合物和磷酸化-Tyr371-CBL-E2-底物肽复合物的结构,并将其与已知的 CBL-E2-底物肽复合物的结构进行了比较。结构和生化分析表明,CBL 采用自动抑制的 RING 构象,其中 RING 的 E2 结合表面与 CBL 结合,以降低 E2 的亲和力。Tyr371 磷酸化通过诱导 LHR 构象变化来激活 CBL,从而消除自动抑制、翻转 RING 结构域和 E2 接近底物结合位点,并将 RING 结构域转化为增强的 E2 结合模块。这种激活是 RTK 泛素化所必需的。我们的结果提出了一种通过自动抑制和磷酸化诱导的激活来调节 c-Cbl 活性的机制。

相似文献

1
Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.
Nat Struct Mol Biol. 2012 Jan 22;19(2):184-92. doi: 10.1038/nsmb.2231.
3
SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
J Mol Biol. 2021 Apr 16;433(8):166880. doi: 10.1016/j.jmb.2021.166880. Epub 2021 Feb 20.
4
Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b.
Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20579-84. doi: 10.1073/pnas.1110712108. Epub 2011 Dec 7.
6
The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme.
J Biol Chem. 2010 Jul 30;285(31):23687-98. doi: 10.1074/jbc.M109.091157. Epub 2010 Jun 4.
7
The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.
Exp Cell Res. 2005 Dec 10;311(2):281-93. doi: 10.1016/j.yexcr.2005.09.015. Epub 2005 Oct 24.
8
Phosphorylation control of the ubiquitin ligase Cbl is conserved in choanoflagellates.
Protein Sci. 2018 May;27(5):923-932. doi: 10.1002/pro.3397. Epub 2018 Apr 14.

引用本文的文献

1
Tuning ubiquitin transfer by RING E3 ubiquitin ligases through the linchpin residue.
Life Sci Alliance. 2025 Aug 5;8(10). doi: 10.26508/lsa.202503394. Print 2025 Oct.
2
Beyond destruction: emerging roles of the E3 ubiquitin ligase Hakai.
Cell Mol Biol Lett. 2025 Jan 20;30(1):9. doi: 10.1186/s11658-025-00693-y.
5
DTX3L ubiquitin ligase ubiquitinates single-stranded nucleic acids.
Elife. 2024 Oct 8;13:RP98070. doi: 10.7554/eLife.98070.
9
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches.
Mol Cancer. 2024 Jul 25;23(1):148. doi: 10.1186/s12943-024-02046-3.
10
Deciphering the Selectivity of CBL-B Inhibitors Using All-Atom Molecular Dynamics and Machine Learning.
ACS Med Chem Lett. 2024 Jun 5;15(7):1017-1025. doi: 10.1021/acsmedchemlett.4c00047. eCollection 2024 Jul 11.

本文引用的文献

1
Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b.
Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20579-84. doi: 10.1073/pnas.1110712108. Epub 2011 Dec 7.
2
Autoregulation of Parkin activity through its ubiquitin-like domain.
EMBO J. 2011 Jun 21;30(14):2853-67. doi: 10.1038/emboj.2011.204.
3
CARD-mediated autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration.
Mol Cell. 2011 Jun 10;42(5):569-83. doi: 10.1016/j.molcel.2011.04.008. Epub 2011 May 5.
4
Structural regulation of cullin-RING ubiquitin ligase complexes.
Curr Opin Struct Biol. 2011 Apr;21(2):257-64. doi: 10.1016/j.sbi.2011.01.003. Epub 2011 Feb 1.
5
Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia.
Nat Genet. 2010 Sep;42(9):794-800. doi: 10.1038/ng.641. Epub 2010 Aug 8.
6
The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme.
J Biol Chem. 2010 Jul 30;285(31):23687-98. doi: 10.1074/jbc.M109.091157. Epub 2010 Jun 4.
7
Cbl and human myeloid neoplasms: the Cbl oncogene comes of age.
Cancer Res. 2010 Jun 15;70(12):4789-94. doi: 10.1158/0008-5472.CAN-10-0610. Epub 2010 May 25.
8
Cbl controls EGFR fate by regulating early endosome fusion.
Sci Signal. 2009 Dec 22;2(102):ra86. doi: 10.1126/scisignal.2000217.
10
Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
Nature. 2009 Aug 13;460(7257):904-8. doi: 10.1038/nature08240. Epub 2009 Jul 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验